Literature DB >> 17051347

A revised method of troponin exchange in permeabilised cardiac trabeculae using vanadate: functional consequences of a HCM-causing mutation in troponin I.

Laura C Preston1, Hugh Watkins, Charles S Redwood.   

Abstract

In order to incorporate human cardiac troponin I (TnI) and troponin C (TnC) into guinea pig skinned cardiac trabeculae, fibres were treated with vanadate to extract endogenous TnI and TnC using established protocols. After addition of human TnI and TnC force was inadequately restored and it was found that the vanadate treatment had unexpectedly also removed some troponin T. To recover Ca(2+)-sensitive force, the fibres had to be incubated with all three troponin subunits. Using this revised method, the hypertrophic cardiomyopathy-causing mutation TnI Gly203Ser had no significant effect on Ca(2+)-sensitivity of force production, contrasting with our earlier report of decreased Ca(2+)-sensitivity which was likely caused by the unexpectedly harsh effect of vanadate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17051347     DOI: 10.1007/s10974-006-9079-0

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  21 in total

1.  Factors contributing to troponin exchange in myofibrils and in solution.

Authors:  M She; D Trimble; L C Yu; J M Chalovich
Journal:  J Muscle Res Cell Motil       Date:  2000       Impact factor: 2.698

Review 2.  A new look at thin filament regulation in vertebrate skeletal muscle.

Authors:  J M Squire; E P Morris
Journal:  FASEB J       Date:  1998-07       Impact factor: 5.191

3.  Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy.

Authors:  D Szczesna; R Zhang; J Zhao; M Jones; G Guzman; J D Potter
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

4.  Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy.

Authors:  B C Knollmann; J D Potter
Journal:  Trends Cardiovasc Med       Date:  2001-07       Impact factor: 6.677

5.  A synthetic peptide mimics troponin I function in the calcium-dependent regulation of muscle contraction.

Authors:  J E Van Eyk; J D Strauss; R S Hodges; J C Rüegg
Journal:  FEBS Lett       Date:  1993-06-01       Impact factor: 4.124

6.  Functional consequences of the mutations in human cardiac troponin I gene found in familial hypertrophic cardiomyopathy.

Authors:  F Takahashi-Yanaga; S Morimoto; K Harada; R Minakami; F Shiraishi; M Ohta; Q W Lu; T Sasaguri; I Ohtsuki
Journal:  J Mol Cell Cardiol       Date:  2001-12       Impact factor: 5.000

7.  A novel method of extraction of TnC from skeletal muscle myofibrils.

Authors:  L D Allhouse; J D Potter; C C Ashley
Journal:  Pflugers Arch       Date:  1999-04       Impact factor: 3.657

8.  Phosphorylation of human cardiac troponin I G203S and K206Q linked to familial hypertrophic cardiomyopathy affects actomyosin interaction in different ways.

Authors:  Yi Deng; Anja Schmidtmann; Sebastian Kruse; Vladimir Filatov; Ludwig M G Heilmeyer; Kornelia Jaquet; Rolf Thieleczek
Journal:  J Mol Cell Cardiol       Date:  2003-11       Impact factor: 5.000

9.  Familial hypertrophic cardiomyopathy mutations in troponin I (K183D, G203S, K206Q) enhance filament sliding.

Authors:  Jan Köhler; Ying Chen; Bernhard Brenner; Albert M Gordon; Theresia Kraft; Donald A Martyn; Michael Regnier; Anthony J Rivera; Chien-Kao Wang; P Bryant Chase
Journal:  Physiol Genomics       Date:  2003-07-07       Impact factor: 3.107

10.  Effects of troponin-I extraction with vanadate and of the calcium sensitizer EMD 53998 on the rate of force generation in skinned cardiac muscle.

Authors:  A Arner; J D Strauss; C Svensson; J C Rüegg
Journal:  J Mol Cell Cardiol       Date:  1995-01       Impact factor: 5.000

View more
  3 in total

1.  Synchronous in situ ATPase activity, mechanics, and Ca2+ sensitivity of human and porcine myocardium.

Authors:  P J Griffiths; H Isackson; R Pelc; C S Redwood; S S Funari; H Watkins; C C Ashley
Journal:  Biophys J       Date:  2009-11-04       Impact factor: 4.033

Review 2.  Cell biology of sarcomeric protein engineering: disease modeling and therapeutic potential.

Authors:  Brian R Thompson; Joseph M Metzger
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

3.  Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI.

Authors:  Jianfeng Du; Jing Liu; Han-Zhong Feng; M M Hossain; Nariman Gobara; Chi Zhang; Yuejin Li; Pierre-Yves Jean-Charles; Jian-Ping Jin; Xu-Pei Huang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-04-11       Impact factor: 4.733

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.